A New Way to Rapidly Develop Biomanufacturing Capacity and Add Greater Value to the Decision to Build

Investing capital in capacity expansion when a drug is early in development is challenging. There are new manufacturing models that reduce risk and add value to your decisions through a concept called optionality Balancing options and critically evaluated risk against…

Continue reading